Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
All articles
Showing 241–252 of 411 articles
- Interpret the evidence
Why a trial of a different tripeptide cannot answer for KPV
KPV is a three-amino-acid fragment of alpha-melanocyte-stimulating hormone. An older randomized study in people with ulcerative colitis investigated a separate three-amino-acid molecule called K(D)PT. The similar names can obscure which peptide was actually tested.
KPV3 sources (2007–2026)
- Explore study findings
Why Lipopeptide Names a Class Rather Than One Substance
A lipopeptide has both a peptide component and a lipid component. Lipids interact differently with water than many peptide chains do, so joining the two can influence where the material goes or how it assembles.
Lipopeptide2 sources (2026)
- Check methods and identity
What Collagen Measurements Showed for Two Palmitoyl Peptides
Adding a fatty-acid part creates a lipopeptide, but the amino-acid portion still affects the material's behavior. A 2026 study of two palmitoyl pentapeptides, or lipid-linked chains of five amino acids, compared their effects on skin-related cell measurements.
Lipopeptide1 source (2026)
- Explore study findings
Why Some Lipopeptides Form Tapes and Others Form Micelles
A 2026 study compared how two defined lipopeptides formed such structures. Lucas de Mello and colleagues examined a palmitoyl pentapeptide used in cosmetic research and a related compound with changes in its charged amino acids. They compared the two in different salt forms and environments.
Lipopeptide1 source (2026)
- Understand the science
How Lipopeptides Were Studied as Part of a Skin Delivery System
Lipopeptides add a lipid component, which can affect interactions with a membrane or a carrier. A 2026 psoriasis study used engineered lipopeptides as part of a delivery system. It illustrates the difference between a carrier and the substance intended to act on a target.
Lipopeptide1 source (2026)
- Explore study findings
What a Skin Immunity Study Reveals About Bacterial Lipopeptides
A chain with an attached lipid is one kind of lipopeptide, and microbes as well as laboratories can produce materials in this broad class. A 2026 study of bacterial lipopeptides asked how certain soluble materials affected a signal released by skin cells.
Lipopeptide1 source (2026)
- Check methods and identity
What a Human Wrinkle Study Tested for One Palmitoyl Lipopeptide
A peptide is a short chain of amino acids joined by peptide bonds. Adding a lipid to that chain can change how a material behaves in a topical product. Palmitoyl pentapeptide, often abbreviated pal-KTTKS, is one specific example. It is not a synonym for the catalog term Lipopeptide.
Lipopeptide2 sources (2005, 2026)
- Interpret the evidence
What pediatric clinic records add to the liraglutide evidence
Liraglutide is a modified peptide that activates the glucagon-like peptide-1, or GLP-1, receptor. In 2026, investigators examined health records to see how blood sugar measures changed in young people with type 2 diabetes who received liraglutide in a clinical setting.
Liraglutide3 sources (2025, 2026)
- Check methods and identity
Why a type 1 diabetes study measured C-peptide
Liraglutide is a modified GLP-1 receptor agonist peptide. Its effects on blood glucose in type 2 diabetes led researchers to ask a narrower question in people with long-standing type 1 diabetes. Could the medicine preserve any insulin-making function that remained?
Liraglutide2 sources (2025, 2026)
- Explore study findings
What exercise and liraglutide changed in a weight-maintenance study
Liraglutide is a modified GLP-1 receptor agonist peptide. A 2026 analysis of the S-LiTE trial examined whether exercise, liraglutide or both changed measurements of blood vessel health after participants had already lost weight through a supervised program.
Liraglutide1 source (2026)
- Understand the science
How a stroke trial explored insulin resistance
Liraglutide is a peptide that activates the GLP-1 receptor. A 2026 analysis of the LAMP trial explored whether the association between liraglutide and recurrent stroke differed with participants’ starting insulin resistance.
Liraglutide3 sources (2025, 2026)
- Explore study findings
Why a five-week body composition study reported amounts and percentages
Liraglutide is a modified GLP-1 receptor agonist. A 2026 report from a small randomized study looked at how body composition changed during a short period, with special attention to the difference between the amount of lean tissue and its share of total body weight.
Liraglutide1 source (2026)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
